Evaluating the Tolerability and Safety Profile of Switching from Rituximab to Ocrelizumab: A Real World Evaluation of Patients with Relapsing Forms of Multiple Sclerosis

This Study is
No Longer Enrolling

Details
Age

Adult

Phase

III/IV - A combination of phases: (3) Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants. and (4) Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.

Type of Study

Treatment

Locations

University of Colorado Hospital

Study ID

Protocol Number: 16-1354

More information available at ClinicalTrials.gov: NCT02980042

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers